| Manager, Post Production & Video Services |
Hyderabad (Office) |
India |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Oct 04, 2024 |
| Associate Director, Finance and Strategy & Growth Activation Communications |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Oct 02, 2024 |
| Director, Communications-Finance/Strategy & Growth Activation |
Basel (City) |
Switzerland |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Sep 26, 2024 |
| Communication & Patient Advocacy Manager (f/m/d) |
Vienna |
Austria |
International |
CTS |
Communications & Public Affairs |
Sep 24, 2024 |
| Manager, US Policy & Issues Communications |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Sep 18, 2024 |
| Public Affairs Manager |
Ankara Gimat |
Turkey |
International |
Innovative Medicines |
Communications & Public Affairs |
Sep 13, 2024 |
| Manager, US Channel Operations & Publishing |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Sep 05, 2024 |
| EA & Program Coordinator |
Beijing (Beijing) |
China |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Sep 03, 2024 |
| Patient Engagement Lead |
İstanbul Kavacık |
Turkey |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Sep 03, 2024 |
| Comms & Engagement Manager |
Amsterdam |
Netherlands |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Aug 27, 2024 |
| Government Affairs Manager |
Moscow (City) |
Russian Fed. |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Iul 29, 2024 |
| Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Communications & Public Affairs |
Iul 09, 2024 |
| Executive Director, Public Affairs LaCan Region |
East Hanover |
USA |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Mai 09, 2024 |
| Director, Public Affairs |
Shanghai (Shanghai) |
China |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
Mai 06, 2024 |